Article
Dalbavancin-resistant Staphylococcus epidermidis in vivo selection following a prosthetic joint infection: phenotypic and genomic characterization
3 Sept 2024
Abstract excerpt
Abstract Background Dalbavancin is a lipoglycopeptide antibiotic with a wide spectrum of activity against Gram-positive bacteria, including MDR isolates. Its pharmacokinetic properties and administration patterns could be useful for the treatment of bone and joint infections, especially prosthetic joint infections (PJIs). Introduction We report the case of an 80-year-old man who experienced an acute...
Topics
Join the communities discussing this publication.
